This broad genetic panel screens for a wide range of genes linked to hereditary breast and ovarian cancer. It includes high-risk genes like BRCA1, BRCA2, and TP53, as well as moderate-risk genes such as ATM, CHEK2, and PALB2 to help refine risk assessment and treatment planning.
Primarily autosomal dominant, though some genes follow autosomal recessive patterns.
ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM, MLH1, MSH2, MSH6, NBN, NF1, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53
Hereditary Breast and Ovarian Cancer, Breast Cancer, Ovarian Cancer
Methodology: | NGS |
Depth of Coverage: | 450x |
Sample Type: | Blood |
Container: | EDTA Vacutainer (Purple Top) |
Shipping Conditions: | Refrigerated (2-8 ℃) |
Max Transit Time: | 72 hours |
16 Days